Ayrton Bangolo | Oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Ayrton Bangolo | Oncology | Best Researcher Award

Dr at Hackensack University Medical Center, United States

Dr. Ayrton I. Bangolo, MBBS, MD, is a board-certified internal medicine physician and current Hematology and Oncology fellow at Hackensack University Medical Center, New Jersey. With extensive medical training spanning across multiple countries, he graduated from Tianjin Medical University in China with an MBBS and gained ECFMG certification after excelling in USMLE exams. Dr. Bangolo has held significant positions in various esteemed medical institutions, including a residency at Palisades Medical Center, NJ. He has showcased his expertise through clinical practice, externships, and observerships in internal medicine, endocrinology, nephrology, and interventional radiology. His dedication to research and community health has been recognized with accolades such as awards at HMH research day. Dr. Bangoloā€™s background is enriched with a global perspective, which contributes to his comprehensive approach to patient care and medical innovation.

Profile

Scholar

Education šŸŽ“

Ph.D. Fellowship in Hematology and Oncology (2024-Present): Hackensack University Medical Center, NJ, enrolled in an ACGME-accredited program. Residency in Internal Medicine (2021-2024): Palisades Medical Center, North Bergen, NJ, successfully completed a full-term ACGME-accredited residency. Transitional Year Residency (2020-2021): Palisades Medical Center, NJ, completed with exemplary performance. MBBS Degree (June 2016): Tianjin Medical University, China, graduated with credentials equivalent to MD. USMLE Certification: Passed USMLE Steps 1, 2 CK, and 3 on the first attempt, affirming ECFMG certification and eligibility for medical licensure in the U.S. Externships and Observerships: Clinical experience at Endocrine Associates, Nortonā€™s Suburban Hospital, and Ngaliema Clinic among others, contributing to multidisciplinary expertise in internal medicine and specialty areas.

Ā Experience šŸ’¼

Hematology and Oncology Fellow (2024-Present): Hackensack University Medical Center, NJ, contributing to advanced clinical research and patient care in an ACGME-accredited fellowship. Internal Medicine Residency (2021-2024): Palisades Medical Center, North Bergen, NJ, completed core rotations with a focus on comprehensive patient care. Transitional Year Residency (2020-2021): Provided care across multiple medical disciplines at Palisades Medical Center, NJ. Externship in Endocrinology (2019-2020): Engaged in specialized practice under Dr. Hisham Alrefai at Endocrine Associates, KY. Observership in Nephrology (2019): Gained nephrology insights with Dr. Mohammed El Kheir at Nortonā€™s Suburban Hospital, KY. Interventional Radiology Observership (2019): Participated under Dr. Mahmoud Samman, contributing to a deeper understanding of interventional procedures. Clinical Clerkship (2015-2016): Acquired foundational medical practice skills at Ngaliema Clinic, DR Congo.

Awards and Honors šŸ†

2nd Place Research Poster: Honored for the study ā€œRacial/Ethnic and Socioeconomic Differences in Colon Cancer Surgeryā€ during the HMH North Region Fellow/Residents Research Day. UN Sustainable Development Goals Contribution: Published impactful research with Elsevier (2019-2021), emphasizing global health initiatives. Recognition for Excellence: Commended for clinical contributions during externships and observerships in Kentucky. Top Medical Graduate: Recognized as a distinguished graduate from Tianjin Medical University. USMLE Success: Passed all USMLE examinations on the first attempt, underscoring strong academic and practical medical knowledge.

Research Focus šŸ”

Hematology & Oncology: Ongoing research in treatment protocols and health disparities, focusing on patient outcomes and innovative care practices. Racial and Socioeconomic Health Disparities: Investigated disparities in surgical treatments for colon cancer, contributing to policy discussions and medical strategies. Global Health Contributions: Published research aligning with United Nationsā€™ goals, influencing international health practices. Medical Imaging & Diagnostics: Explored advancements in imaging for early disease detection and effective management. Endocrinology & Nephrology: Applied deep learning to medical data for better diagnostic outcomes and patient treatment plans. Patient Care & Clinical Innovation: Emphasizes integrative methods in patient treatment, fostering evidence-based and empathetic healthcare practices.

Conclusion šŸ“

Dr. Ayrton I. Bangoloā€™s proven track record in clinical practice, research contributions, and scholarly publications position him as a strong contender for the Best Researcher Award. His focus on impactful research and addressing health disparities is commendable. By expanding his research collaborations and further emphasizing his mentorship roles, Dr. Bangoloā€™s candidacy would be even more compelling.

Publications šŸ“š

  • Title: Ultrasound performance using the EU-TIRADS score in the diagnosis of thyroid cancer in Congolese hospitals
    Authors: J Bukasa-Kakamba, P Bayauli, N Sabbah, J Bidingija, A Atoot, B Mbunga, …
    Year: 2022
    Journal: Scientific Reports 12 (1), 18442
    Citations: 9

 

  • Title: Racial/ethnic and socioeconomic differences in breast cancer surgery performed and delayed treatment: mediating impact on mortality
    Authors: P Fwelo, KOS Nwosu, TE Adekunle, O Afolayan, O Ahaiwe, AA Ojaruega, …
    Year: 2023
    Journal: Breast Cancer Research and Treatment 199 (3), 511-531
    Citations: 7

 

  • Title: Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States
    Authors: D Lew, F Kamal, K Phan, K Randhawa, S Cornwell, AI Bangolo, …
    Year: 2022
    Journal: World Journal of Clinical Oncology 13 (11), 907
    Citations: 7

 

  • Title: Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights
    Authors: AI Bangolo, C Trivedi, I Jani, S Pender, H Khalid, B Alqinai, A Intisar, …
    Year: 2023
    Journal: World Journal of Gastroenterology 29 (25), 3984
    Citations: 6

 

  • Title: Primary cardiac sarcoma: clinical characteristics and prognostic factors over the past 2 decades
    Authors: A Bangolo, P Fwelo, KM Iyer, S Klinger, L Tavares, S Dey, AA Chacko, …
    Year: 2023
    Journal: Diseases 11 (2), 74
    Citations: 6

 

  • Title: The overall quality of evidence of recommendations surrounding nutrition and diet in inflammatory bowel disease
    Authors: S Weissman, BM Fung, A Bangolo, A Rashid, BF Khan, AKG Tirumala, …
    Year: 2023
    Journal: International Journal of Colorectal Disease 38 (1), 98
    Citations: 6

 

  • Title: The Spectrum of Thyroid Nodules at Kinshasa University Hospital, Democratic Republic of Congo: A Cross-Sectional Study
    Authors: JK Bukasa, P Bayauli-Mwasa, BK Mbunga, A Bangolo, W Kavula, …
    Year: 2022
    Journal: International Journal of Environmental Research and Public Health 19 (23), 16203
    Citations: 6

 

  • Title: Outcomes of patients with gastrointestinal stromal tumors in the past decade
    Authors: A Bangolo, P Fwelo, T Al-Qatish, J Bukasa-Kakamba, T Lee, AG Cayago, …
    Year: 2023
    Journal: Medical Sciences 11 (3), 54
    Citations: 5

 

TANUMA MISTRY | CLINICAL ONCOLOGY | Best Researcher Award

Posted on by ScienceFather

Dr. TANUMA MISTRY | CLINICAL ONCOLOGY | Best Researcher Award

 

Ms at CHITTARANJAN NATIONAL CANCER INSTITUTE, India

Tanuma Mistry is a dedicated research fellow in the Department of Pathology and Cancer Screening at Chittaranjan National Cancer Institute, Kolkata, India. She holds a Master of Science in Zoology from the University of Calcutta, with extensive research experience in life sciences, specifically cancer research. Tanuma has received prestigious awards, including the SERB International Travel and CSIR-Foreign Travel Grant. She is a member of notable societies such as ESMO, ASCO, and AACR. Tanuma’s research focuses on molecular techniques and targeted therapeutics, contributing significantly to various high-impact publications in the field of oncology.

profile

Scopus

Academic Qualification:šŸŽ“

Master of Science (2016): M.Sc. in Zoology from University of Calcutta, Kolkata, India. Ā Marks obtained: 75.1%. Bachelor of Science (2013):
B.Sc. in Zoology from University of Calcutta (Vidyasagar College for Women), Kolkata, India. Marks obtained: 68%. Higher Secondary Examination (10+2): West Bengal Council of Higher Secondary Education (WBCHSE), Kolkata, India. Ariadaha Sarbamangala Balika Vidyalaya
Marks obtained (Best of 4): 70.75%. Secondary Examination (10): West Bengal Board of Secondary Education (WBBSE), Kolkata, India.
Ariadaha Sarbamangala Balika VidyalayaĀ Marks obtained: 71.75%

Other Qualification:šŸ§¬

CSIR NET-JRF (June 2018) in Life Science (AIR-118). West Bengal State Eligibility Test (WBSET) 2018 in Life Science The Graduate Aptitude Test in Engineering (GATE)-XL 2022 in Life Science

Awards:šŸ…

SERB International Travel: ESMO Asia Congress 2023, Singapore. CSIR-Foreign Travel Grant: EBCC-13; Barcelona, Spain. 13th East Zonal Oncology Symposium 2024: 2nd Position in Poster Presentation

Membership of Societies:

The Zoological Society, Kolkata, Ā European Society of Medical Oncology (ESMO) [Id: 561295], šŸ‡ŗšŸ‡ø American Society of Clinical Oncology (ASCO) [Id: 7278374], Ā American Association for Cancer Research (AACR) [Id: 1304687]

Research Experience:šŸ”¬

2019 – Till Date: CSIR Research Fellow Department of Pathology & Cancer Screening, Chittaranjan National Cancer Institute
Registered under Jadavpur University, Department of Life Science and Biotechnology, Kolkata, India

Skills in Laboratory Techniques:

Molecular techniques: Isolation of DNA, RNA, and Protein, PCR, RFLP, RT-PCR, Electrophoresis, Immunohistochemistry, Western Blotting, Northern Blotting, Southern Blotting, DNA sequencing, MTT assay. Computational skills: Operating systems: Windows, Mac Software: Microsoft Office, Statistical Software Sigma Graph & Plot, GraphPad Prism, SPSS, Mendeley, EndNote

Review during M.Sc:

Behavioral Ecology and Conservation Strategies of Greater One-horned Rhinoceros (Rhinoceros unicornis):
Under the Supervision of Dr. Rakesh Tamang

Project during M.Sc:

Localized Survey of Two Important Bio-resources (TEA & FISH) Types and Practices at Dooars Region of North Bengal:
Under the Supervision of Dr. Sumit Homechoudhury

Publications Top Notes

  • Title: Emerging futuristic targeted therapeutics: A comprising study towards a new era for the management of TNBC
    Authors: Mistry T, Nath A, Pal R, Ghosh S, Sahoo PK, Mahata S, Sarkar S, Choudhury T, Nath P, Alam N, Nasare VD
    Year: 2024
  • Title: Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer
    Authors: Nath A, Mitra S, Mistry T, Pal R, Nasare VD
    Year: 2021
    Journal: Medical Oncology
    DOI: 10.1007/s12032-021-01610-x
  • Title: Mitotic checkpoint defects: en route to cancer and drug resistance
    Authors: Sarkar S, Sahoo PK, Mahata S, Pal R, Ghosh D, Mistry T, Ghosh S, Bera T, Nasare VD
    Year: 2021
  • Title: PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer
    Authors: Mahata S, Sahoo PK, Pal R, Sarkar S, Mistry T, Ghosh S, Nasare VD
    Year: 2022
    Journal: Medical Oncology
  • Title: Assessment of quality of life among advanced ovarian cancer patients in a tertiary care hospital in India
    Authors: Sarkar S, Sahoo PK, Pal R, Mistry T, Mahata S, Chatterjee P, Vernekar M, Mandal S, Bera T, Nasare VD
    Year: 2022
  • Title: Premalignant and malignant lesions of oral cavity in eastern India: a hospital-based study
    Authors: Sahoo PK, Sarkar S, Ghosh D, Mahata S, Pal R, Mistry T, Ghosh S, Roy A, Bucha H, Mandal S, Nasare VD
    Year: 2021
  • Title: Outcome of 3-year follow-up with induction vs first line chemotherapy in oral cancer patients: An observational hospital-based study
    Authors: Sahoo PK, Bhowmick AK, Sarkar S, Mahata S, Pal R, Mistry T, Ghosh S, Choudhury T, Kumar RS, Mandal S, Datta S, Nath P, Mukherjee KK, Nasare VD
  • Title: Polymorphism of transporter genes contributes to variations in treatment outcomes and adverse events in platinum-based chemotherapy-treated oral cancer patients
    Authors: Sahoo PK, Mistry T, Sarkar S, Ghosh D, Mahata S, Pal R, Ghosh S, Roy A, Bucha H, Mandal S, Datta S, Nasare VD
    Year: 2024
  • Title: Impact of Low BMI and Nutritional Status on Quality of Life and Disease Outcome in Breast Cancer Patients: Insights from a Tertiary Cancer Center in India
    Authors: Mistry T, Pal R, Ghosh S, Choudhury T, Mandal S, Nath P, Alam N, Nasare VD
    Year: 2024

 

Angelika Długosz-Pokorska | cancer research | Women Researcher Award

Posted on by ScienceFather

Ā Dr. Angelika Długosz-Pokorska | cancer research |Women Researcher Award

Ā Dr at Medical University of ÅĆ³dÅŗ,Ā  Poland

A dedicated researcher and project leader at the Medical University of Lodz, Poland, with expertise in pharmacological characterization and anticancer drug development. As Principal Investigator and Co-investigator, led projects funded by prestigious grants like OPUS and SONATA, focusing on opioid peptide analogs and alpha-methylidene-delta-lactones. Supervising international student exchanges and engaging in expert activities, workshops, and editorial work. Recognized with numerous awards for scientific excellence, including Rector’s Awards and IF=8.638 for publication series on opioid mimetics and glutathione peroxidase. Committed to advancing medical science through innovative research and academic leadership.

Profile

  1. Scopus

 

  1. Orcid

šŸ“œ Employment History:

Research Associate (2017-present) Medical University of Lodz, Poland; Faculty of Medicine. Co-investigator (2016-2021)
Project: Rational design and pharmacological characterization of chimeric cyclic opioid peptide analogs targeting multiple receptors
Grant: OPUS 9, project ID 2015/17/B/ST5/00153. Principal Investigator (2016-2021) Project: Analysis of the anticancer activity of new synthetic alpha-methylidene-delta-lactones in selected cell lines Grant: SONATA, project ID 2015/17/D/NZ3/02226. Supervisor, Project Manager, and Principal Investigator (2018-present) Project: Analysis of the anticancer activity and molecular mechanism of action of new hybrid molecules containing uracil skeleton with an exo-cyclic methylene group Grant: PRELUDIUM13, project ID UMO-2017/25/N/NZ3/01039

šŸ“š Short Research Training:

University of Rouen, France (2014) Laboratoire de Neuropsychopharmacologie ExpƩrimentale

šŸŒ Activities:

  • Expert Activity/Reviewer (2024)
    Platform: Qeios
  • International Student Exchanges and ERASMUS Supervision (2024)
    Engaging in initiatives and participating in European Union programs, overseeing ERASMUS students.
  • Participation in Scientific Workshops and Research Teams (2024)
    Engaging in workshops aimed at exchanging experiences, self-improvement, and organization.
  • Editorial Work (2023-present)
    Journal: Reviewer for Breast Cancer-Tokyo, ISSN 1340-6868, eISSN 1880-4233.

šŸ† Awards and Distinctions:

2022: First-level Special Award for Outstanding Didactic Work by Academic Teachers Medical University of Lodz.

2020: Team Distinction from the Faculty of Chemistry Nicolaus Copernicus University in Toruń Rector’s Award Medical University of Lodz Second-degree scientific award for a series of publications titled: ‘Investigation of the Anticancer Properties of Synthetic Analogues of Compounds Isolated from Plants’. (Impact Factor – 8.034). Polish Intelligent Development Award – Nomination.

2019: Investigation of Anticancer Activity of Synthetic Analogues of Methylenolactones”, IF=4.026PTBioch Bursary Scholarship 44th FEBS Congress “From Molecules to Living Systems”. Rector’s Award Medical University of Lodz Second Prize for Publication: ‘Synthetic Analogues of Coumarin as Novel Agents with Anticancer Activity’. (Impact Factor = 4.173). Rector’s Award Medical University of Lodz Team Second award for Publication Series:

2017: Rector’s Award Medical University of Lodz First Prize for Publication Series: “Synthesis and Investigation of Biological Activity of Opioid Mimetics and Glutathione Peroxidase”. (IF=8.638). Rector’s Award Medical University of Lodz Team First Prize for Publication Series: “Anticancer Properties of Novel Synthetic Dicoumarins”. (IF=6.221) “Investigation of Anticancer Activity of Sesquiterpene Lactones”. (IF=4.994)

2016: Rector’s Award Medical University of Lodz First Prize for Publication Series: “Anticancer Properties of Novel Synthetic Lactones in Combination with Known Anticancer Drugs”. (IF = 8.835)

Publications Top Notes šŸ“

  • Title: Synthesis of New Chiral Ī²-Carbonyl Selenides with Antioxidant and Anticancer Activity Evaluation-Part I
    • Authors: Laskowska, A., Pacuła-Miszewska, A.J., Obieziurska-Fabisiak, M., et al.
    • Journal: Materials
    • Year: 2024
    • Volume: 17
    • Pages: 1ā€“15
    • Summary: This study focuses on the synthesis of new chiral Ī²-carbonyl selenides and evaluates their antioxidant and anticancer activities, providing valuable insights into potential therapeutic agents.

 

  • Title: New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF7 Cancer Cells
    • Authors: Długosz-Pokorska, A., Perlikowska, R., Janecki, T., et al.
    • Journal: Biologics: Targets and Therapy
    • Year: 2023
    • Volume: 17
    • Pages: 69ā€“83
    • Summary: This article presents a novel uracil analog with potential to reverse resistance to Taxol in MCF7 cancer cells, indicating its promising role as an anticancer agent.

 

  • Title: New Uracil Analog- U-359 can Reverse Resistance to Taxol in MCF-7 cancer cells
    • Authors: Długosz-Pokorska, A., Perlikowska, R., Janecki, T., et al.
    • Journal: Acta Biochimica Polonica
    • Year: 2023
    • Volume: 70
    • Pages: 56
    • Summary: This study explores another uracil analog’s potential to reverse resistance to Taxol in MCF-7 cancer cells, indicating a promising avenue for further research.

 

  • Title: The Influence of Long Carbon Chains on the Antioxidant and Anticancer Properties of N-Substituted Benzisoselenazolones and Corresponding Diselenides
    • Authors: Pacuła-Miszewska, A.J., Obieziurska-Fabisiak, M., Jastrzębska, A., et al.
    • Journal: Pharmaceuticals
    • Year: 2023
    • Volume: 16
    • Pages: 1ā€“11
    • Summary: This research investigates the impact of long carbon chains on the antioxidant and anticancer properties of N-substituted benzisoselenazolones and corresponding diselenides, providing valuable insights into structure-activity relationships.

 

  • Title: Attachment of Chiral Functional Groups to Modify the Activity of New GPx Mimetics
    • Authors: Laskowska, A., Pacuła-Miszewska, A., Długosz-Pokorska, A., et al.
    • Journal: Materials
    • Year: 2022
    • Volume: 16
    • Pages: 1ā€“14
    • Summary: This study explores the modification of GPx mimetics’ activity through the attachment of chiral functional groups, offering potential strategies for enhancing therapeutic effects.